drugset / Trial / NCT03760640

A Study of LY900014 in a Medtronic Pump

NCT03760640

Phase 2 Completed 42 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes (T1D). The study will consist of two treatment periods of 4 weeks.

Timeline

Start
2019-02-18
Primary completion
2019-10-07
Completion
2019-10-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Lispro Protein / enzyme biologic 100 unknown Subcutaneous